
|Articles|October 11, 2018
Sharing Insight on Myeloma, CAR T, and More in San Francisco
Author(s)Unknown Author
We visited San Francisco, California for a State of the Science Summit on Hematologic Malignancies. The meeting covered novel agents and combinations in lymphoma, updates in acute and chronic leukemias, and modalities in the management of multiple myeloma.
Advertisement
We visited San Francisco, California for a State of the Science SummitTM on Hematologic Malignancies. The meeting covered novel agents and combinations in lymphoma, updates in acute and chronic leukemias, and modalities in the management of multiple myeloma.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
2
Steven W. Pipe, MD, on the Implications of the Final Data From Hemgenix’s HOPE-B Trial
3
Around the Helix: Cell and Gene Therapy Company Updates – December 17, 2025
4
End-of-Study Results From Hemgenix’s HOPE-B Trial
5




































